The ABCC2 1249G>A (rs2273697) and ABCC2 −24C>T (rs717620) polymorphisms can affect plasma LCM concentrations and treatment efficacy among a population of Uygur pediatric patients with epilepsy, causing these patients to become resistant to LCM. Here, ABCC2 is linked to epilepsy.